Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists attenuate the profibrotic response induced by TGF-β1 in renal interstitial fibroblasts

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Wang, Weiming ^a   Liu, Feng ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ALPHA SMOOTH MUSCLE ACTIN; CIGLITAZONE; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE; ACTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; KIDNEY FAILURE; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; DRUG POTENTIATION; FIBROSIS; KIDNEY; METABOLISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

RATTUS;

ACTINS; ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; FIBROBLASTS; FIBRONECTINS; FIBROSIS; KIDNEY; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; PPAR GAMMA; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 38749146876     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/62641     Document Type: Article

References (29)

1. M. Zeisberg F. Strutz G. A. Müller Role of fibroblast activation in inducing interstitial fibrosis. Journal of Nephrology 13, supplement 3 2000 S111 S120
2. Y. Guan M. D. Breyer Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney International 60 1 2001 14 30
3. Y. Guan Y. Zhang L. Davis M. D. Breyer Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. American Journal of Physiology 273 6 1997 F1013 F1022
4. T. Yang D. E. Michele J. Park Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. American Journal of Physiology 277 6 1999 F966 F973
5. T. Ishizuka O. Ito oito@mail.cc.tohoku.ac.jp L. Tan Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. Hypertension Research 26 11 2003 929 936
6. S. Wakino swakino@sc.itc.keio.ac.jp K. Hayashi S. Tatematsu Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats. Hypertension Research 28 3 2005 255 262
7. A. B. Walker E. K. Naderali P. D. Chattington R. E. Buckingham G. Williams Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes 47 5 1998 810 814
8. L.-J. Ma C. Marcantoni M. F. Linton S. Fazio A. B. Fogo Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney International 59 5 2001 1899 1910
9. J. Weissgarten Weissgarten@asaf.health.gov.il S. Berman S. Efrati M. Rapoport Z. Averbukh L. Feldman Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats. Nephrology Dialysis Transplantation 21 5 2006 1198 1204
10. U. Panchapakesan S. Sumual C. A. Pollock carpol@med.usyd.edu.au X. Chen PPAR-γ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. American Journal of Physiology 289 5 2005 F1153 F1158
11. B. Guo D. Koya M. Isono T. Sugimoto A. Kashiwagi M. Haneda haneda@belle.shiga-med.ac.jp Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes 53 1 2004 200 208
12. A. Maeda S. Horikoshi T. Gohda T. Tsuge K. Maeda Y. Tomino yasu@med.juntendo.ac.jp Pioglitazone attenuates TGF-β1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)γ Cell Biology International 29 6 2005 422 428
13. A. Gumieniczek kzchl@asklepios.am.lublin.pl Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. Life Sciences 74 5 2003 553 562
14. H. Kasuga Y. Ito S. Sakamoto Effects of anti-TGF-β type II receptor antibody on experimental glomerulonephritis. Kidney International 60 5 2001 1745 1755
15. S.-L. Lin R.-H. Chen Y.-M. Chen Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. Journal of the American Society of Nephrology 16 9 2005 2702 2713
16. F. Zheng A. Fornoni S. J. Elliot Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPAR-γ activation. American Journal of Physiology 282 4 2002 639 648
17. D.-H. Cho Y. J. Choi S. A. Jo I. Jo Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPAR gamma-independent signaling pathways. Journal of Biological Chemistry 279 4 2004 2499 2506
18. H. Sawano M. Haneda T. Sugimoto K. Inoki D. Koya R. Kikkawa 15-deoxy-Δ12,14-prostaglandin J 2 inhibits IL-1β-induced cyclooxygenase-2 expression in mesangial cells. Kidney International 61 6 2002 1957 1967
19. S. Zafiriou S. R. Stanners T. S. Polhill P. Poronnik C. A. Pollock Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses. Kidney International 65 5 2004 1647 1653
20. F. J. Villarreal fvillarr@ucsd.edu J. Asbun Peroxisome proliferator-activated receptors ligands, oxidative stress, and cardiac fibroblast extracellular matrix turnover. Hypertension 44 5 2004 621 622
21. T. Asano asano@intmed2.med.kyushu-u.ac.jp M. Wakisaka M. Yoshinari Peroxisome proliferator-activated receptor γ1 (PPARγ1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation. Biochimica et Biophysica Acta 1497 1 2000 148 154
22. Y. Ping H. Xiaohui L. Yongxue Z. Yali Activation of peroxisome proliferator-activated receptor α in human endothelial cells increases plasminogen activator inhibitor type-1 expression. Chinese Medical Journal 116 2003 1 29 33
23. S. Zafiriou S. R. Stanners S. Saad T. S. Polhill P. Poronnik C. A. Pollock carpol@med.usyd.edu.au Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. Journal of the American Society of Nephrology 16 3 2005 638 645
24. U. Panzer A. Schneider Y. Guan Effects of different PPARγ-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis. Kidney International 62 2 2002 455 464
25. Y. Shi yshi@molbio.princeton.edu J. Massagué j-massague@ski.mskcc. org Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 6 2003 685 700
26. A. Leask a.leask@rfc.ucl.ac.uk D. J. Abraham TGF-β signaling and the fibrotic response. The FASEB Journal 18 7 2004 816 827
27. K. C. Flanders flanderk@dce41.nci.nih.gov Smad3 as a mediator of the fibrotic response. International Journal of Experimental Pathology 85 2 2004 47 64
28. W. Wang V. Koka H. Y. Lan hlan@bcm.tmc.edu Transforming growth factor-β and Smad signalling in kidney diseases. Nephrology 10 1 2005 48 56
29. J. Yang C. Dai Y. Liu liuy@msx.upmc.edu Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. The American Journal of Pathology 163 2 2003 621 632